Ionis Pharmaceuticals Inc
NASDAQ:IONS
Wall Street
Price Targets
IONS Price Targets Summary
Ionis Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
IONS
is 56.49 USD
with a low forecast of 29.29 USD and a high forecast of 89.25 USD.
IONS Last Price Targets
Ionis Pharmaceuticals Inc
The latest public price target was made on Feb 3, 2023 by
Unknown Analyst
from
Leerink Partners
,
who expects
IONS
stock to
drop by 19%
over the next 12 months.
You can read more about this price target by viewing
the article on Benzinga.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Unknown Analyst
Leerink Partners
|
34
USD
Downside 19% |
1 year ago
Feb 3, 2023
|
SVB Leerink Maintains Market Perform on Ionis Pharmaceuticals, Raises Price Target to $34
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IONS's stock price target?
Price Target
56.49
USD
According to Wall Street analysts, the average 1-year price target for
IONS
is 56.49 USD
with a low forecast of 29.29 USD and a high forecast of 89.25 USD.
What is Ionis Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
11%
For the last 8 years the
compound annual growth rate for
Ionis Pharmaceuticals Inc's revenue is
14%.
The projected
CAGR
for the next 3 years is
11%.
You don't have any saved screeners yet
